ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Kiromic BioPharma Inc

Kiromic BioPharma Inc (KRBP)

0.60
0.00
(0.00%)
Closed December 05 4:00PM
0.60
0.00
( 0.00% )
Pre Market: 7:00PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

KRBP News

Official News Only

KRBP Discussion

View Posts
ANTI-BAGHOLDER ANTI-BAGHOLDER 2 months ago
KRBP

Kiromic BioPharma Reports Favorable 10-Month Follow-Up Results for the First Patient Treated in its Deltacel-01 Clinical Trial

https://www.otcmarkets.com/stock/KRBP/news/Kiromic-BioPharma-Reports-Favorable-10-Month-Follow-Up-Results-for-the-First-Patient-Treated-in-its-Deltacel-01-Clinical?id=454504
๐Ÿ‘๏ธ0
glenn1919 glenn1919 11 months ago
KRBP...........................https://stockcharts.com/h-sc/ui?s=KRBP&p=W&b=5&g=0&id=p86431144783
๐Ÿ‘๏ธ0
glenn1919 glenn1919 11 months ago
KRBP....................https://stockcharts.com/h-sc/ui?s=KRBP&p=W&b=5&g=0&id=p86431144783
๐Ÿ‘๏ธ0
willlbone willlbone 1 year ago
Chap 11 likely.
๐Ÿ‘๏ธ0
splintered sunlight splintered sunlight 1 year ago
Big time.

Seriously big time!!!!
๐Ÿ‘๏ธ0
Disquisition Disquisition 1 year ago
It DUMPED
๐Ÿ‘๏ธ0
splintered sunlight splintered sunlight 1 year ago
What the hell happened to KRBP?

From over $20 to fifty cents in less than a year.........
๐Ÿ‘๏ธ0
Renee Renee 1 year ago
KRBP delisted from the Nasdaq to the OTC. PPS dropped 56% to .69 in after hours.

https://otce.finra.org/otce/dailyList?viewType=Additions
๐Ÿ‘๏ธ0
Awl416 Awl416 1 year ago
Kiromic BioPharma Common Stock to Begin Trading on the OTC Pink Sheets on September 14
๐Ÿ‘๏ธ0
Monksdream Monksdream 1 year ago
Kiromic Biopharma Inc NASDAQ: KRBP*

GoSymbol lookup



*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements
Health Care : Biotechnology | Company profile
Kiromic BioPharma, Inc. is an artificial intelligence (AI) driven, end-to-end allogenic cell therapy company. The Company is engaged in developing the multi-indication allogeneic T cell therapy that exploits the natural potency of the Gamma Delta T cell (GDT) to target solid tumors. The Procel, Isocel, and Deltacel product platform candidates consist of allogeneic cell therapy candidates that are in the preclinical development stage. Its Procel product candidate consists of engineered GDTs targeting PD-L1. Its Isocel product candidate consists of engineered GDTs targeting Mesothelin Isoform 2 positive tumors (Iso-Meso). Its Deltacel product candidate consists of non-engineered GDTs used to treat solid tumors. Its Allogenic Lead Exogenous Isoforms (ALEXIS)-PRO-1 trial candidate is its allogeneic GDT therapy product targeting PD-L1. Its ALEXIS-ISO-1 trial candidate is its allogenic GDT therapy product targeting an isoform of Mesothelin that is present in tumor cells, namely Isomeso.
๐Ÿ‘๏ธ0
Triple nickle Triple nickle 2 years ago
Out for the time being
๐Ÿ‘๏ธ0
koolmc koolmc 2 years ago
see how long it lasts on the announcement at least got news this time.
๐Ÿ‘๏ธ0
Invest-in-America Invest-in-America 2 years ago
KRBP: Its 68% price uptick right now in the A.H., has my new DDAmanda-Price-Prognosticator blowing fuses!!! (See below!!)

๐Ÿ‘๏ธ0
koolmc koolmc 2 years ago
in the red now fun while it lasted looking for another entry gl.
๐Ÿ‘๏ธ0
Awl416 Awl416 2 years ago
Wild
๐Ÿ‘๏ธ0
glenn1919 glenn1919 2 years ago
KRBP...................................https://stockcharts.com/h-sc/ui?s=KRBP&p=W&b=5&g=0&id=p86431144783
๐Ÿ‘๏ธ0
Awl416 Awl416 2 years ago
There she goes
๐Ÿ‘๏ธ0
koolmc koolmc 2 years ago
5.20's nice pull that crazy move next week biatch
๐Ÿ‘๏ธ0
koolmc koolmc 2 years ago
going again
๐Ÿ‘๏ธ0
koolmc koolmc 2 years ago
hit 4.80 :) took some of table, i wanna see this to the crazy run lol.
๐Ÿ‘๏ธ0
koolmc koolmc 2 years ago
nice chomp chomp
๐Ÿ‘๏ธ0
Awl416 Awl416 2 years ago
Big block
๐Ÿ‘๏ธ0
wickerman wickerman 2 years ago
$KRBP $5+ explosion yesterday but I guess the company is now worth less after IND news...this small cap market is a complete joke controlled and owned by naked shorts. I bought a ton today. Good luck to all.

https://ih.advfn.com/stock-market/NASDAQ/kiromic-biopharma-KRBP/stock-news/90675566/kiromic-biopharma-submits-investigational-new-drug
๐Ÿ‘๏ธ0
BEIJING BILL BEIJING BILL 2 years ago
If this can break 5.11 vatch out then. Kimchi got the memo from Brudge Netvorks
๐Ÿ‘๏ธ0
Awl416 Awl416 2 years ago
Fun day
๐Ÿ‘๏ธ0
Alias12345 Alias12345 2 years ago
Wow, someone's stop loss got taken out. Now let's see what happens.
๐Ÿ‘๏ธ0
BEIJING BILL BEIJING BILL 2 years ago
KRBP inturusting here.
๐Ÿ‘๏ธ0
wickerman wickerman 2 years ago
My key words are these -->

Favorable Safety Results are Last Component Needed to Complete the Nonclinical Module of the Company's IND Application

Does this $hitty stock action make sense? Hell no who can argue that?
However this is when you load up and wait until PH1 because that was dang good news for an emerging bio startup with AI tech that treats LUNG CANCER tumors >> JMHO << but I've done a ton of DD on this just wait a storm is coming...

IND Submission and Activation of Clinical Trial Process on Track for the First Quarter and Second Quarter of this Year, Respectively

Kiromic BioPharma, Inc.

The histopathology report, authored by a certified veterinary pathologist, revealed no adverse microscopic findings related to the administration of Deltacelโ„ข alone or as part of the combination treatment.

"We're pleased to receive a clean pharmacology profile with no adverse findings and are encouraged by the preclinical results to-date in support of our planned IND submission. This histopathology report includes results from more than 500 histological sections from multiple organs of mice treated with Deltacelโ„ข, with the combination treatment of Deltacelโ„ข and a non-biological anti-tumor therapy, or mice left untreated. This study completes the necessary dataset for authoring the Pharmacology Report of the Efficacy Study, which is an essential component of the nonclinical module of our IND application," stated Leonardo Mirandola, Ph.D., Chief Scientific Officer of Kiromic BioPharma.

"These findings are in line with what we observed in a study evaluating Deltacelโ„ข monotherapy at a dose more than 7 times higher than the maximum dose planned for the Deltacelโ„ข clinical trial, and they confirm that Deltacelโ„ข was well tolerated in mice, even when given as part of a combination therapy that further boosted its potency," continued Dr. Mirandola. "Kiromic plans to submit the Deltacelโ„ข IND application to the U.S. FDA in this first quarter, and if accepted, plans to begin the activation of the clinical trial process in the second quarter of 2023. The planned clinical study will evaluate Deltacelโ„ข in combination with a non-biological anti-tumor therapy for the treatment of non-small cell lung cancer."

Kiromic BioPharma, Inc. is a clinical-stage, fully integrated biotherapeutics company using its proprietary DIAMOND® artificial intelligence (AI) 2.0 target discovery engine to detect, develop, and commercialize cell therapies with a therapeutic focus on immuno-oncology. Kiromic is developing a multi-indication allogeneic cell therapy platform that exploits the natural potency of Gamma Delta T-cells to target solid cancers. Kiromic's DIAMOND® AI is where data science meets target identification to dramatically compress the years and hundreds of millions of dollars required to develop a live drug. The Company maintains offices in Houston, Texas. To learn more, visit www.kiromic.com and connect with us on Twitter and LinkedIn.

https://www.businesswire.com/news/home/20230228005440/en/Kiromic-BioPharma-Reports-Favorable-Deltacel%E2%84%A2-Preclinical-Pharmacology-Results
๐Ÿ‘๏ธ0
TheFinalCD TheFinalCD 2 years ago
KEY WORD: PRE-CLINICAL

NOT EVEN PHASE 1

FLOAT LOOKS SMALL

https://finance.yahoo.com/news/kiromic-biopharma-arranges-10-million-124800993.html
๐Ÿ‘๏ธ0
wickerman wickerman 2 years ago
$KRBP nice news out this could squeeze over .50

https://www.benzinga.com/pressreleases/23/02/b31089226/kiromic-biopharma-reports-favorable-deltacel-preclinical-pharmacology-results
๐Ÿ‘๏ธ0
glenn1919 glenn1919 2 years ago
KRBP................................https://stockcharts.com/h-sc/ui?s=KRBP&p=W&b=5&g=0&id=p86431144783
๐Ÿ‘๏ธ0
howlerdog99 howlerdog99 2 years ago
Is there news Monday I hope we see .50
๐Ÿ‘๏ธ0
TheFinalCD TheFinalCD 2 years ago
what happened ah?
๐Ÿ‘๏ธ0
moondogaz moondogaz 2 years ago
Keep on watch list.. This one will have it's day.
๐Ÿ‘๏ธ0
moondogaz moondogaz 2 years ago
Keep on watch list.. This one will have it's day.
๐Ÿ‘๏ธ0
moondogaz moondogaz 2 years ago
.40 next stop.
๐Ÿ‘๏ธ0
moondogaz moondogaz 2 years ago
Microsoft ai roll out tomorrow...Google ai roll out wed.
๐Ÿ‘๏ธ0
moondogaz moondogaz 2 years ago
Sleep well.dream big.
๐Ÿ‘๏ธ0
moondogaz moondogaz 2 years ago
Chasing will start pre-market. Watch big buys roll in. .28 will be breached pre-market.
๐Ÿ‘๏ธ0
moondogaz moondogaz 2 years ago
I think we nailed it at right price,right time.
๐Ÿ‘๏ธ0
wickerman wickerman 2 years ago
$KRBP super close hoping for a multi-bagger here $$
๐Ÿ‘๏ธ0
Curt D Curt D 2 years ago
It wants to go. Moves easily.
๐Ÿ‘๏ธ0
moondogaz moondogaz 2 years ago
Exactly what I paid.
๐Ÿ‘๏ธ0
Curt D Curt D 2 years ago
I jumped back in at .23. Good timing. Or lucky timing.
๐Ÿ‘๏ธ0
moondogaz moondogaz 2 years ago
Heating up
๐Ÿ‘๏ธ0
81vette 81vette 2 years ago
accumulation @ 90day high,loading and holding started jan 20th,couple of flippers now posting unknown analysts' negative opinions smh,trying to flip a low float for a few pennies when thats the spread,oooops lol,newbies smh
๐Ÿ‘๏ธ0
glenn1919 glenn1919 2 years ago
KRBP.......https://stockcharts.com/h-sc/ui?s=KRBP&p=W&b=5&g=0&id=p8643114478
๐Ÿ‘๏ธ0
81vette 81vette 2 years ago
parabolic again,gotta love it
๐Ÿ‘๏ธ0
81vette 81vette 2 years ago
.24 demand building/new support,double bounce,reloading now
๐Ÿ‘๏ธ0
81vette 81vette 2 years ago
shares available to short dropped 700% today,float getting locked up,going to 0 shortable could put a nice squeeze on KRBP
๐Ÿ‘๏ธ0

Your Recent History

Delayed Upgrade Clock